[Beta-adrenergic inhibitors and atherogenic risk].
Jacotot
B
B
Richard
J L
JL
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000494:pharmacology; D001161:Arteriosclerosis / Q000139:chemically induced*; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D012306:Risk
D000319:Adrenergic beta-Antagonists; D008055:Lipids; D008074:Lipoproteins
Inhibiteurs bêta-adrénergiques et risque athérogène.